Business
Fine for dodgy Nurofen claims increased to $6m
The makers of Nurofen have been fined a record $6 million for misleading consumers over its “specific pain range” tablet claims.
Business
The makers of Nurofen have been fined a record $6 million for misleading consumers over its “specific pain range” tablet claims.
News
The consumer watchdog is appealing what it says is an inadequate fine imposed by the Federal Court against the makers of Nurofen over misplaced claims of targeted pain relief.
Get InDaily in your inbox. Daily. The best local news sent straight to your inbox every workday at lunchtime.
Thanks for signing up to the InDaily newsletter.
Nurofen will change the packaging on its targeted pain relief products in New Zealand after an Australian ruling found it was selling the same product under different labels.
Back pain? Period pain? Migraines? For Nurofen, it’s all the same.